Vericel Corp · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 8≥ implied

Feb 27 '25±11.0%▼−6.11%×0.56

May 8 '25±10.8%▲+3.46%×0.32

Jul 31 '25±11.6%▼−14.07%×1.22

Nov 6 '25±15.6%▲+4.17%×0.27

Jan 13 '26±12.9%▲+1.26%×0.10

Q1 FY26±14.8%▲+1.59%×0.11

May 7 '26±9.1%▼−4.49%×0.49

Q2 FY26±13.2%▲+2.12%×0.16

quarterimplied−20%0+20%realized×

Q2 FY26±13.2%▲+2.12%×0.16

May '26±9.1%▼−4.49%×0.49

Q1 FY26±14.8%▲+1.59%×0.11

Jan '26±12.9%▲+1.26%×0.10

Nov '25±15.6%▲+4.17%×0.27

Jul '25±11.6%▼−14.07%×1.22

2 older reports

May '25±10.8%▲+3.46%×0.32

Feb '25±11.0%▼−6.11%×0.56

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2 of 3

7disclosed supplier and customer ties in SEC filingsSEC filings

318managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

4tracked funds holding VCELN-PORT · Aug 31 '26

0.49%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

VCEL report session

No linked exposure.

Oct 22impliedImplied move: ±11.2% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.